FDA Grades Pharma on Post-Market Safety Promises
Published Date: 4/24/2026
Notice
Summary
The FDA just released its yearly report showing how drug and biologics companies are doing with their promised safety and effectiveness studies after their products hit the market. This update affects drug makers who must keep up with these important follow-ups to ensure medicines stay safe and work well. The report helps everyone know who’s on track and who needs to step up, with no new costs or deadlines but a clear spotlight on ongoing commitments.
Free Policy Watch
New rules are filed every week. Most people never see them.
Pick a topic. PRIA watches every federal rule and tells you when one hits your household.
Pick a topic to get started
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in